Biofrontera receives Nasdaq bid price deficiency notice, 180 days to cure

Biofrontera Inc.

Nasdaq notified Biofrontera on May 8, 2025 that common stock bid price closed below $1.00 for 33 consecutive business days.
Company has until November 5, 2025 to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not compliant by deadline, company may seek additional time via reverse stock split or face potential delisting.
Management will monitor bid price and consider available options; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.